Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Board Changes

18 Aug 2025 10:00

RNS Number : 6033V
Phoenix Group Holdings PLC
18 August 2025
 

LEI: 2138001P49OLAEU33T68

 

18 August 2025

 

Phoenix Group Holdings plc - Board Changes

 

The Board of Phoenix Group Holdings plc ("Phoenix" or the "Group") announces the following changes:

 

· Belinda Richards, Group Independent Non-Executive Director, will be retiring from the Board on 24 August 2025, having served almost eight years.

 

· Karin Cook will be appointed to the Group Board as an Independent Non-Executive Director, and as a member of its Risk and Sustainability Committees with effect from 25 August 2025. Within the Group, Karin is currently an Independent Non-Executive Director of the Group's Life Companies[1] Boards and a member of its Risk Committee, and SunLife Limited. Karin is also an Independent Non-Executive Director of NatWest Holdings Limited (holding company of NatWest Group's ring-fenced operations including its retail, commercial and wealth businesses) and a member of its Board Audit and Remuneration Committees. Karin brings over thirty years of customer-focused, digital, operational and transformation experience gained from previous leadership roles in multiple large groups (including as the Chief Operating Officer of Quilter plc, Director, Group Operations at Lloyds Banking Group and senior roles at HSBC, Morgan Stanley and Goldman Sachs). Karin has a commitment to diversity, equity and inclusion and has been recognised in the past in the LGBT Great's Top 50 Executive Allies, the FT OUTstanding LGBT+ Role Model list and as Stonewall Senior Champion of the Year.

 

· Mark Gregory, Group Independent Non-Executive Director and Chair of the Group Board Risk Committee will be appointed as an Independent Non-Executive Director of the Group's Life Companies Boards, member of the Life Companies Nomination Committee and also Chair of its Risk Committee with effect from 25 August 2025.

 

· Eleanor Bucks, Group Independent Non-Executive Director will be appointed as a member of the Group Audit Committee with effect from 25 August 2025.

 

· David Scott, Group Shareholder Nominated Non-Executive Director by Aberdeen Group plc ("Aberdeen") will retire from the Board on 31 August 2025.

 

· Siobhan Boylan, Chief Financial Officer ("CFO") of Aberdeen will be appointed in his place with effect from 1 September 2025. Siobhan has strong executive director level experience in her current role at Aberdeen and previous roles as CFO of Coutts & Co and CFO of Brewin Dolphin (a constituent of the FTSE 250 until its acquisition by Royal Bank of Canada in 2022). Until recently, she was also a Non-Executive Director of Jupiter Fund Management plc bringing additional experience in a non-executive capacity to the Board.

 

Commenting on the changes, Sir Nicholas Lyons, Chair of Phoenix said:

"On behalf of the Board, I would like to thank Belinda for her commitment, challenge and outstanding contribution to the Group during her tenure and I wish her every success for the future.

 

We are delighted that Karin and Mark have agreed to take on additional responsibilities. Their appointments are aligned to further increasing interaction and connectivity, whilst maintaining independence between our Group and Life Companies' Boards with their collective backgrounds being of great value to discussions at both board levels.

 

Both Eleanor and Karin will provide additional skills and ensure the required membership composition for their respective committees is maintained in accordance with the UK Corporate Governance Code 2024. Their strong challenge and experience will be welcomed by the current members of the Audit, Risk and Sustainability committees.

 

Finally, I would like to thank David for his excellent contribution to the Board since joining on 11 May 2023. We wish David every success and happiness in his retirement, and I look forward to welcoming Siobhan as a new Non-Executive Director to the Board."

 

This announcement is made pursuant to LR 6.4.6 and 6.4.8 of the Listing Rules. There is no further information required to be notified under Listing Rule 6.4.8 with reference to Karin Cook and Siobhan Boylan's appointments referenced above.

 

Enquiries:

Media

Shellie Wells, Corporate Communications Director, Phoenix Group

+44 (0) 204 559 3031

Investors

Claire Hawkins, Director of Corporate Affairs & Brand, Phoenix Group+44 (0) 204 559 3161

Tom Blackwell, Managing Director, FTI

+44 (0) 7747 133 919

Joanne Roberts, Investor Relations Director, Phoenix Group

+44 (0) 204 559 4673

 


[1] The term "Life Companies" refers collectively to the Group's insurance subsidiaries: Phoenix Life CA Limited, Phoenix Life Limited, ReAssure Life Limited, ReAssure Limited and Standard Life Assurance Limited.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPKPBDABKDBFD
Date   Source Headline
10th Apr 20249:43 amRNSDirector/PDMR Shareholding
9th Apr 20248:33 amRNSDirector/PDMR Shareholding
8th Apr 20242:15 pmRNSNotice of AGM
3rd Apr 20241:02 pmRNSDirector/PDMR Shareholding
2nd Apr 20245:26 pmRNSTotal Voting Rights
2nd Apr 20244:45 pmRNSDirector/PDMR Shareholding
28th Mar 20245:40 pmRNSDirector/PDMR Shareholding
27th Mar 20244:20 pmRNSAnnual Financial Report
27th Mar 20242:45 pmRNSDirector/PDMR Shareholding
22nd Mar 20247:00 amRNS2023 Annual Financial Report
6th Mar 20242:00 pmRNSDirector/PDMR Shareholding
1st Mar 20249:35 amRNSTotal Voting Rights
6th Feb 20245:17 pmRNSDirector/PDMR Shareholding
2nd Feb 202410:56 amRNSTotal Voting Rights
1st Feb 20247:00 amRNS2023 Trading Statement
8th Jan 20245:09 pmRNSDirector/PDMR Shareholding
2nd Jan 20243:15 pmRNSTotal Voting Rights
11th Dec 20236:13 pmRNSBlock listing Interim Review
6th Dec 20234:28 pmRNSDirector/PDMR Shareholding
5th Dec 202311:42 amRNSFinal Result of Tender Offer
5th Dec 202310:22 amRNSIndicative Result of Tender Offer
5th Dec 20237:10 amRNSPublication of Final Terms
1st Dec 202311:46 amRNSTotal Voting Rights
28th Nov 20235:46 pmRNSIssue of Debt and Tender Maximum Acceptance Amount
27th Nov 20238:20 amRNSTender Offers and New Issue
24th Nov 202311:05 amRNSDirector Declaration
23rd Nov 20232:00 pmRNSPublication of Supplementary Prospectus
23rd Nov 202310:00 amRNSDirectorate Change
13th Nov 20237:00 amRNSUpgrade of near-term cash generation targets
7th Nov 20235:10 pmRNSDirector/PDMR Shareholding
1st Nov 20232:07 pmRNSDirector/PDMR Shareholding
31st Oct 20232:30 pmRNSHolding(s) in Company
25th Oct 20231:17 pmRNSDirector/PDMR Shareholding
25th Oct 20231:16 pmRNSDirector/PDMR Shareholding
9th Oct 202312:40 pmRNSDirector/PDMR Shareholding
9th Oct 202311:20 amRNSDirector/PDMR Shareholding
4th Oct 202310:00 amRNSBoard Changes
2nd Oct 20233:00 pmRNSPublication of Supplementary Prospectus
2nd Oct 20231:35 pmRNSTotal Voting Rights
29th Sep 20237:00 amRNSDirector/PDMR Shareholding
28th Sep 20232:46 pmRNSDirector/PDMR Shareholding
28th Sep 202312:49 pmRNSAvailability of Interim Financial Report
28th Sep 20237:00 amRNSInterim Financial Report
18th Sep 20237:00 amRNS2023 Interim Results
14th Sep 202310:00 amRNSHY23 reporting update
8th Sep 20239:33 amRNSDirector/PDMR Shareholding
1st Sep 20231:29 pmRNSTotal Voting Rights
9th Aug 20235:04 pmRNSDirector/PDMR Shareholding
1st Aug 20233:16 pmRNSTotal Voting Rights
7th Jul 20233:08 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.